Related Experiment Video
Updated: Jul 17, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Regulatory policies on medicines for psychiatric disorders: is Europe on target?
Abstract:
The European Medicines Agency (EMEA) is the regulatory body that provides the institutions of the European Community with the best possible scientific advice on the quality, safety and efficacy of medicinal products. Drugs approved by the EMEA are automatically marketable in all the European member states. Since the beginning of the EMEA's activities a number of drugs acting on the central nervous system obtained marketing authorisation. This editorial highlights some aspects of the EMEA rules that may negatively affect the evaluation of medicines for psychiatric disorders.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Drug Regulation
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Psychosis and Antipsychotic Drugs: Overview